In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Align Technology

This article was originally published in The Gray Sheet

Executive Summary

Maker of Invisalign clear, removable appliances for treatment of dental misalignment files preliminary prospectus with the Securities and Exchange Commission Nov. 14 for a proposed initial public offering of up to $200 mil. in common stock. The number of shares and price per share have not yet been determined. Proceeds would be used to expand manufacturing capacity, fund a national advertising campaign and other marketing activities, and continue product development. Invisalign is designed to compete with conventional metal or ceramic braces made by such firms as 3M Company, Sybron International and Dentsply International, and yet to be less burdensome to the wearer. The device gained 510(k) clearance from FDA in November 1998 and commenced commercial sales in July 1999. Each Invisalign appliance is worn over the teeth for two weeks before disposal of and replacement by the next appliance in a series. As of October, Align has trained over 5,300 orthodontists in Invisalign use, representing over 60% of U.S. and Canadian orthodontists. The Santa Clara, California firm generated sales of $3.2 mil. for the nine months ended Sept. 30 and a net loss of $53.3 mil. Underwriters include Deutsche Banc Alex Brown, Bear Stearns, J.P. Morgan and Robertson Stephens
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

MT014119

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel